US Broker Ratings

Tenet Healthcare Corporation (THC) Stock Analysis: A 40% Upside Potential Beckons Investors

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. medical care facilities industry, presents a compelling opportunity for investors with its robust growth potential and strategic positioning in..

The Cooper Companies, Inc. (COO) Stock Analysis: Potential 45.59% Upside Driven by Healthcare Innovation

The Cooper Companies, Inc. (NYSE: COO) stands out in the healthcare sector with its innovative approach to medical instruments and supplies, particularly focusing on contact lenses and women’s health products...

ICON plc (ICLR) Stock Analysis: Unveiling a 13.55% Upside Potential for Investors

ICON plc (NASDAQ: ICLR), a leading clinical research organization based in Dublin, Ireland, is drawing the attention of savvy investors with its promising 13.55% potential upside. As a key player..

Molina Healthcare Inc (MOH): Analyst Consensus and Stock Analysis Reveal Limited Upside Potential

Molina Healthcare Inc (NYSE: MOH) presents a mixed bag for investors, as its current financial and stock performance metrics reveal both challenges and opportunities in the healthcare sector. With a..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 12.69% Upside Potential and Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, specifically within the drug manufacturing industry, is a company that continues to capture the attention of investors. With a current..

Align Technology, Inc. (ALGN) Stock Analysis: Aiming for a 27.79% Upside with Analyst Support

Align Technology, Inc. (NASDAQ: ALGN) has carved a niche for itself in the healthcare sector, specifically within the medical instruments and supplies industry. Best known for its Invisalign clear aligners..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Biotech Giant with a 260% Revenue Growth

Moderna, Inc. (NASDAQ: MRNA) stands as a beacon of innovation in the biotechnology sector, renowned for its pioneering work in messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, Moderna has..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 29.63% Potential Upside

Alcon Inc. (NYSE: ALC), a Swiss-based giant in the healthcare sector, particularly in the medical instruments and supplies industry, offers investors a compelling opportunity with a potential upside of 29.63%...

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 19.31% Potential Upside in the Diagnostics Sector

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, operates within the Diagnostics & Research industry, offering a comprehensive range of laboratory services. With a market capitalization..

Sanofi (SNY) Stock Analysis: Unlocking a 26% Upside Potential Amid Strong Dividend Yield

Sanofi (SNY), a leading player in the healthcare sector, continues to capture the attention of investors with its solid performance metrics and promising growth prospects. With a market capitalization of..

Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare’s Dynamic Terrain with 15% Upside Potential

Baxter International Inc. (NYSE: BAX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market presence spanning numerous regions,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 14.62% Potential Upside for Investors

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, particularly within the medical devices industry, has been catching the attention of investors with its notable..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 17% Potential Upside for Investors

United Therapeutics Corporation (NASDAQ: UTHR), a formidable player in the healthcare sector, offers intriguing prospects for investors with its focus on addressing unmet medical needs through innovative treatments. Known for..

Teva Pharmaceutical Industries (TEVA) Investor Outlook: Navigating Growth with a Promising 18% Upside

Teva Pharmaceutical Industries (NYSE: TEVA), an Israeli giant in the healthcare sector, continues to capture investor interest with its robust portfolio of generic and specialty medicines. As one of the..

Fresenius Medical Care AG (FMS) Stock Analysis: Is a 25.82% Upside on the Horizon for This Healthcare Giant?

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis services and products, commands a significant presence in the healthcare sector. With a market capitalization of $11.62 billion,..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential 21.39% Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry, delivering mission-critical products and services globally. With a market capitalization of..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Promising 15% Upside with Robust Revenue Growth

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors. With a market capitalization of $16.54 billion..

DaVita Inc. (DVA) Stock Analysis: Navigating Growth in Healthcare with Strong ROE and Strategic Positioning

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services, a crucial lifeline for patients suffering from chronic kidney failure across the United..

Dr. Reddy’s Laboratories Ltd (RDY) Investor Outlook: Exploring the 4.65% Potential Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a renowned name in the global pharmaceutical landscape, offers intriguing opportunities for investors amidst a challenging industry backdrop. As a leading player in the..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Navigating a Potential 62.41% Upside Amidst Biotech Innovations

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a notable player in the biotechnology sector, focusing on the development and commercialization of therapies for rare diseases. With its current market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds